Abstract
It has been recognized that cancer-associated mortality is more often a result of the disrupted physiological functions in multiple organs following metastatic dissemination of cancer cells, rather than the presence and growth of the primary tumor. Despite advances in our understanding of the events leading to cancer initiation, growth, and acquisition of invasive properties, we are still unable to effectively treat metastatic disease. It is now being accepted that the secretion of extracellular vesicles, such as exosomes from cancer cells, has a profound impact on the initiation and propagation of metastatic breast cancer. These cancer-secreted vesicles differ from other means of cellular communication due to their capability of bulk delivery and organotropism. Here, we provide an overview of the role of extracellular vesicles in breast cancer metastasis and discuss key areas that may facilitate our understanding of metastatic breast cancer to guide our efforts towards providing better therapies.
Similar content being viewed by others
References
Villarroya-Beltri, C., Baixauli, F., et al. (2014). Sorting it out: regulation of exosome loading. Seminars in Cancer Biology , 28, 3–13.
Hoshino, A., Costa-Silva, B., et al. (2015). Tumour exosome integrins determine organotropic metastasis. Nature , 527(7578), 329–335.
Harris, D. A., Patel, S. H., et al. (2015). Exosomes released from breast cancer carcinomas stimulate cell movement. PloS One , 10(3), e0117495.
McCready, J., Sims, J. D., et al. (2010). Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: a role for plasminogen activation. BMC Cancer , 10, 294.
Melo, S. A., Sugimoto, H., et al. (2014). Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell , 26(5), 707–721.
O'Brien, K., Rani, S., et al. (2013). Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells. European Journal of Cancer , 49(8), 1845–1859.
Singh, R., Pochampally, R., et al. (2014). Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. Molecular Cancer , 13, 256.
Le, M. T., Hamar, P., et al. (2014). miR-200-containing extracellular vesicles promote breast cancer cell metastasis. The Journal of Clinical Investigation , 124(12), 5109–5128.
Smith, Z. J., Lee, C., et al. (2015). Single exosome study reveals subpopulations distributed among cell lines with variability related to membrane content. J Extracell Vesicles , 4, 28533.
Su, J. (2015). Label-free single molecule detection using Microtoroid optical resonators. Journal of Visualized Experiments , 106, e53180.
Tauro, B. J., Greening, D. W., et al. (2013a). Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids. Molecular & Cellular Proteomics , 12(3), 587–598.
Willms, E., Johansson, H. J., et al. (2016). Cells release subpopulations of exosomes with distinct molecular and biological properties. Scientific Reports , 6, 22519.
Koumangoye, R. B., Sakwe, A. M., et al. (2011). Detachment of breast tumor cells induces rapid secretion of exosomes which subsequently mediate cellular adhesion and spreading. PloS One , 6(9), e24234.
Sung, B. H., Ketova, T., et al. (2015). Directional cell movement through tissues is controlled by exosome secretion. Nature Communications , 6, 7164.
Hoshino, D., Kirkbride, K. C., et al. (2013). Exosome secretion is enhanced by invadopodia and drives invasive behavior. Cell Reports , 5(5), 1159–1168.
Purushothaman, A., Bandari, S. K., et al. (2016). Fibronectin on the surface of myeloma cell-derived exosomes mediates exosome-cell interactions. The Journal of Biological Chemistry , 291(4), 1652–1663.
Cho, J. A., Park, H., et al. (2012). Exosomes from breast cancer cells can convert adipose tissue-derived mesenchymal stem cells into myofibroblast-like cells. International Journal of Oncology , 40(1), 130–138.
Luga, V., Zhang, L., et al. (2012). Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell , 151(7), 1542–1556.
Dutta, S., Warshall, C., et al. (2014). Interactions between exosomes from breast cancer cells and primary mammary epithelial cells leads to generation of reactive oxygen species which induce DNA damage response, stabilization of p53 and autophagy in epithelial cells. PloS One , 9(5), e97580.
Yang, M., Chen, J., et al. (2011). Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Molecular Cancer , 10, 117.
Seubert, B., Grunwald, B., et al. (2015). Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice. Hepatology , 61(1), 238–248.
Skog, J., Wurdinger, T., et al. (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nature Cell Biology , 10(12), 1470–1476.
Jung, K. K., Liu, X. W., et al. (2006). Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein. The EMBO Journal , 25(17), 3934–3942.
Zhou, W., Fong, M. Y., et al. (2014). Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell , 25(4), 501–515.
Tominaga, N., Kosaka, N., et al. (2015). Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier. Nature Communications , 6, 6716.
Fong, M. Y., Zhou, W., et al. (2015). Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nature Cell Biology , 17(2), 183–194.
Zhang, L., Zhang, S., et al. (2015). Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature , 527(7576), 100–104.
Xiang, X., Poliakov, A., et al. (2009). Induction of myeloid-derived suppressor cells by tumor exosomes. International Journal of Cancer , 124(11), 2621–2633.
Chow, A., Zhou, W., et al. (2014). Macrophage immunomodulation by breast cancer-derived exosomes requires toll-like receptor 2-mediated activation of NF-kappaB. Scientific Reports , 4, 5750.
Yu, S., Liu, C., et al. (2007). Tumor exosomes inhibit differentiation of bone marrow dendritic cells. Journal of Immunology , 178(11), 6867–6875.
Clayton, A., Al-Taei, S., et al. (2011). Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. Journal of Immunology , 187(2), 676–683.
Liu, C., Yu, S., et al. (2006). Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. Journal of Immunology , 176(3), 1375–1385.
Kosaka, N., Iguchi, H., et al. (2013). Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. The Journal of Biological Chemistry , 288(15), 10849–10859.
Cogolludo, A., Moreno, L., et al. (2009). Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction. Cardiovascular Research , 82(2), 296–302.
King, H. W., Michael, M. Z., et al. (2012). Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer , 12, 421.
Wilson, W. R., & Hay, M. P. (2011). Targeting hypoxia in cancer therapy. Nature Reviews. Cancer , 11(6), 393–410.
Zhao, H., Yang, L., et al. (2016). Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism. eLife , 5, e10250.
Wang, T., Gilkes, D. M., et al. (2014). Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis. Proceedings of the National Academy of Sciences of the United States of America , 111(31), E3234–E3242.
Parolini, I., Federici, C., et al. (2009). Microenvironmental pH is a key factor for exosome traffic in tumor cells. The Journal of Biological Chemistry , 284(49), 34211–34222.
Ban, J. J., Lee, M., et al. (2015). Low pH increases the yield of exosome isolation. Biochemical and Biophysical Research Communications , 461(1), 76–79.
Ostrowski, M., Carmo, N. B., et al. (2010). Rab27a and Rab27b control different steps of the exosome secretion pathway. Nature Cell Biology , 12(1), 19–30 sup pp 11-13.
Bobrie, A., Krumeich, S., et al. (2012). Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Research , 72(19), 4920–4930.
Hendrix, A., Sormunen, R., et al. (2013). Vacuolar H+ ATPase expression and activity is required for Rab27B-dependent invasive growth and metastasis of breast cancer. International Journal of Cancer , 133(4), 843–854.
Zhang, J. X., Huang, X. X., et al. (2012). Overexpression of the secretory small GTPase Rab27B in human breast cancer correlates closely with lymph node metastasis and predicts poor prognosis. Journal of Translational Medicine , 10, 242.
Tauro, B. J., Mathias, R. A., et al. (2013b). Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK)cell-derived exosomal proteins following epithelial-mesenchymal transition. Molecular & Cellular Proteomics , 12(8), 2148–2159.
Garnier, D., Magnus, N., et al. (2012). Cancer cells induced to express mesenchymal phenotype release exosome-like extracellular vesicles carrying tissue factor. The Journal of Biological Chemistry , 287(52), 43565–43572.
Gopal, S. K., Greening, D. W., et al. (2016). Oncogenic epithelial cell-derived exosomes containing Rac1 and PAK2 induce angiogenesis in recipient endothelial cells. Oncotarget , 7, 19709–19722.
Thompson, C. A., Purushothaman, A., et al. (2013). Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes. The Journal of Biological Chemistry , 288(14), 10093–10099.
Hendrix, A., Maynard, D., et al. (2010). Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis. Journal of the National Cancer Institute , 102(12), 866–880.
Peinado, H., Aleckovic, M., et al. (2012). Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nature Medicine , 18(6), 883–891.
Admyre, C., Johansson, S. M., et al. (2007). Exosomes with immune modulatory features are present in human breast milk. Journal of Immunology , 179(3), 1969–1978.
Bissell, M. J., & Hines, W. C. (2011). Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nature Medicine , 17(3), 320–329.
Lim, P. K., Bliss, S. A., et al. (2011). Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Research , 71(5), 1550–1560.
Ono, M., Kosaka, N., et al. (2014). Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells. Science Signaling , 7(332), ra63.
Acknowledgments
We apologize to the authors of those excellent studies we are not able to include in this review due to the space limit. This work was supported by the National Institutes of Health (NIH)/National Cancer Institute (NCI) grants R01CA166020 (SEW) and R01CA163586 (SEW), California Breast Cancer Research Program grant 20IB-0118 (SEW), and Breast Cancer Research Foundation-AACR grant 12-60-26-WANG (SEW).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have declared that no conflict of interest exists.
Rights and permissions
About this article
Cite this article
Chin, A.R., Wang, S.E. Cancer-derived extracellular vesicles: the ‘soil conditioner’ in breast cancer metastasis?. Cancer Metastasis Rev 35, 669–676 (2016). https://doi.org/10.1007/s10555-016-9639-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10555-016-9639-8